(-)-Salcolin B
(-)-Salcolin B (Tricin 4'-O-(threo-β-guaiacylglyceryl) ether) is an isomer of Salcolin B (HY-N16766) and anti-inflammatory agent. (-)-Salcolin B is isolable from Njavara. (-)-Salcolin B downregulates the activities of NF-κB and STAT3, reduces the expressions of iNOS and COX-2, activates the ERK signaling pathway, and inhibits LPS-induced NO and ROS production. (-)-Salcolin B induces Apoptosis. (-)-Salcolin B inhibits TPA (HY-18739)-induced ear edema. (-)-Salcolin B possesses antioxidant activity. (-)-Salcolin B can be used in research related to inflammatory diseases, colon adenocarcinoma, ovarian cancer and breast cancer.
For research use only. We do not sell to patients.
- CAS No.: 1292294-32-6
- Formula: C27H26O11
- Molecular Weight:526.49
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
COX-2 |
STAT3 |
iNOS |
Tricin 4'-O-(threo-β-guaiacylglyceryl) ether (10-40 μg/mL; 15 min) dose-dependently inhibits LPS-induced ROS generation in RAW264.7 cells[1].
Tricin 4'-O-(threo-β-guaiacylglyceryl) ether (10-40 μg/mL; 24 h) dose-dependently inhibits LPS-induced NO generation in RAW264.7 cells[1].
Tricin 4'-O-(threo-β-guaiacylglyceryl) ether (10-40 μg/mL; 8 h) dose-dependently inhibits LPS-induced iNOS transcriptional activity in RAW264.7 cells[1].
Tricin 4'-O-(threo-β-guaiacylglyceryl) ether (10-40 μg/mL; 24 h) dose-dependently inhibits LPS-induced PGE2 generation in RAW264.7 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:mouse macrophage-like RAW264.7 cells
-
Concentration:10-40 μg/mL
-
Incubation Time:24 h
-
Result:Significantly reduced LPS-induced PGE2 production in a dose-dependent manner, with each tested concentration producing a statistically significant decrease compared to LPS-only treated cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR mice (male)[1]
-
Dosage:0.1 mg/ear; 0.5 mg/ear
-
Administration:topical; single dose
-
Result:Suppressed TPA-induced iNOS and COX-2 protein expression in ear tissue, inhibited NF-κB DNA-binding activity, blocked phosphorylation of IKKα/β and IκB, reduced nuclear translocation of p50 and p65, and inhibited STAT3 phosphorylation at both doses.
Reduced cell infiltration and decreased staining for F4/80, CD3, and COX-2 in ear tissue treated with 0.5 mg/ear.
Chemical Information
-
CAS No. 1292294-32-6
-
Molecular Weight 526.49
-
Formula C27H26O11
-
SMILES
O=C1C=2C(OC(=C1)C3=CC(OC)=C(O[C@H]([C@H](O)C4=CC(OC)=C(O)C=C4)CO)C(OC)=C3)=CC(O)=CC2O
-
Synonyms
Tricin 4'-O-(threo-β-guaiacylglyceryl)ether
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)